CYP19A1 and breast cancer: A combined resistance and aerobic exercise program, similar to our study, applied on the older breast cancer survivors undergoing aromatase inhibitor therapy showed that quality of life parameters such as physical functioning, health, pain, general health sense, vitality, social functioning, fatigue, and sleep disorder were improved significantly (Penttinen et al., 2019).